pharmaphorum February 13, 2024
Precision medicine is a hot topic area at the moment – so too is the field of psychedelics for mental health. And then, there’s precision psychiatry.
The state of the mental health of the global population is, fair to say, not in great condition. Globally, 615 million people, or almost 10% of the worldwide population, are currently living with a mental health condition. And more than 50% (320 million people) suffer from major depressive disorder (MDD).
In this episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomed Dr Hans Eriksson, chief medical officer at HMNC Brain Health, a precision psychiatry biopharma company, to discuss his work exploring current studies into the use of ketamine in mental health, HMNC Brain...
Today's Sponsors
Today's Sponsor